Condensed Statements of Operations (Unaudited) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Condensed Statements of Operations (Unaudited)
Net sales	$ 0	$ 0
Operating expenses:
Research and development expenses	258,297	258,620
Professional fees	48,332	47,560
General and administrative expenses	495,323	247,561
Total operating expenses	801,952	553,741
Income (loss) from operations	(801,952)	(553,741)
Other income (expense)
Interest expense	(208,892)	(52,019)
Change in derivative liabilities	(57,140)	(57,203)
Total other income (expense)	(266,032)	(109,222)
Net loss	$ (1,067,984)	$ (662,963)
Net (loss) per common shares (basic and diluted)	$ (0.08)	$ (0.05)
Weighted average shares outstanding
(basic and diluted)	13,289,789	13,163,286